Affiliation:
1. Centre for Diagnosis of Inherited Alpha-1 Antitrypsin Deficiency, Laboratory of Biochemistry and Genetics, Institute for Respiratory Disease, Department of Internal Medicine and Therapeutics , University of Pavia, Fondazione IRCCS Policlinico San Matteo , Pavia , Italy
2. Conresp , Loerzweiler , Germany
Abstract
Abstract
Objectives
Alpha1-antitrypsin deficiency (AATD) is an inherited condition that predisposes individuals to an increased risk of developing lung and liver disease. Even though AATD is one of the most widespread inherited diseases in Caucasian populations, only a minority of affected individuals has been detected. Whereas methods have been validated for AATD testing, there is no universally-established algorithm for the detection and diagnosis of the disorder. In order to compare different methods for diagnosing AATD, we carried out a systematic review of the literature on AATD diagnostic algorithms.
Methods
Complete biochemical and molecular analyses of 5,352 samples processed in our laboratory were retrospectively studied using each of the selected algorithms.
Results
When applying the diagnostic algorithms to the same samples, the frequency of False Negatives varied from 1.94 to 12.9%, the frequency of True Negatives was 62.91% for each algorithm and the frequency of True Positives ranged from 24.19 to 35.15%. We, therefore, highlighted some differences among Negative Predictive Values, ranging from 0.83 to 0.97. Accordingly, the sensitivity of each algorithm ranged between 0.61 and 0.95. We also postulated 1.108 g/L as optimal AAT cut-off value, in absence of inflammatory status, which points to the possible presence of genetic AATD.
Conclusions
The choice of the diagnostic algorithm has a significant impact on the correct diagnosis of AATD, which is essential for appropriate treatment and medical care. The fairly large number of possible false negative diagnoses revealed by the present paper should also warn clinicians of negative results in patients with clinically-suspected AATD.
Subject
Biochemistry, medical,Clinical Biochemistry,General Medicine
Reference34 articles.
1. Stoller, JK, Aboussouan, LS. Alpha1-antitrypsin deficiency. Lancet 2005;365:2225–36. https://doi.org/10.1016/s0140-6736(05)66781-5.
2. Giacopuzzi, E, Laffranchi, M, Berardelli, R, Ravasio, V, Ferrarotti, I, Gooptu, B, et al.. Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency. Hum Mutat 2018;39:1203–13. https://doi.org/10.1002/humu.23562.
3. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818–900. https://doi.org/10.1164/rccm.168.7.818.
4. Popławska, B, Janciauskiene, S, Chorostowska-Wynimko, J. Genetic variants of alpha-1 antitrypsin: classification and clinical implications. Pneumonol Alergol Pol 2013;81:45–54.
5. Köhnlein, T, Janciauskiene, S, Welte, T. Diagnostic delay and clinical modifiers in alpha-1 antitrypsin deficiency. Ther Adv Respir Dis 2010;4:279–87. https://doi.org/10.1177/1753465810376407.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献